Stroke prevention and intervention

References

• Delanty N, Vaughan CJ. Vascular effects of statins in stroke. Stroke 1997; 28(11): 2315–20
   PubMed Web of Science ®Google Scholar
• Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325(18): 1261–6
   Google Scholar
• Sacco RL, Wolf PA, Kannel WB, et al. Survival and recurrence following stroke: the Framingham Study. Stroke 1982; 13(3): 290–5
   PubMed Web of Science ®Google Scholar
• Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke 1988; 19(8): 937–41
   Google Scholar
• Norris JW, Zhu CZ, Bornstein NM, et al. Vascular risks of asymptomatic carotid stenosis. Stroke 1991; 22(12): 1485–90
   PubMed Web of Science ®Google Scholar
• Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 1979; 242(23): 2562–71
   PubMedGoogle Scholar
• Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996; 124(6): 548–56
   PubMed Web of Science ®Google Scholar
• Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335(14): 1001–9
   PubMed Web of Science ®Google Scholar
• Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): a randomized controlled trial. JAMA 1996; 276(10): 785–91
   Google Scholar
• Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347(9004): 781–6
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308(6921): 81–106 [Erratum, BMJ 1994; 308(6943): 1540]
   PubMed Web of Science ®Google Scholar
• Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321 (3): 129–35
   PubMed Web of Science ®Google Scholar
• Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988; 296(6618): 313–6
   PubMed Web of Science ®Google Scholar
• Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 1996; 60(2): 197–9
   PubMed Web of Science ®Google Scholar
• Sivenius J, Laakso M, Penttila IM, et al. The European Stroke Prevention Study: results according to sex. Neurology 1991; 41(8): 1189–92
   Google Scholar
• Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143(1–2): 1–13
   PubMed Web of Science ®Google Scholar
• Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321(8): 501–7
   Google Scholar
• Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989; 1(8649): 1215–20
   PubMed Web of Science ®Google Scholar
• Weisberg LA. The efficacy and safety of ticlopidine and aspirin in non-whites: analysis of a patient subgroup from the Ticlopidine Aspirin Stroke Study. Neurology 1993; 43(1): 27–31
   Google Scholar
• CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348(9038): 1329–39
   PubMed Web of Science ®Google Scholar
• Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990; 322(12): 863–8
   PubMed Web of Science ®Google Scholar
• Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non rheumatic atrial fibrillation. N Engl J Med 1990; 323(22): 1505–11
   PubMed Web of Science ®Google Scholar
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343(8899): 687–91
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348(9028): 633–8
   PubMedGoogle Scholar
• EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342(8882): 1255–62
   PubMed Web of Science ®Google Scholar
• Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333(1): 11–7
   PubMed Web of Science ®Google Scholar
• Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993; 329(8): 524–9
   PubMed Web of Science ®Google Scholar
• Azar AJ, Koudstaal PJ, Wintzen AR, et al. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction. Ann Neurol 1996; 39(3): 301–7
   Google Scholar
• Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332(15): 993–7
   PubMed Web of Science ®Google Scholar
• European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991; 337(8752): 1235–43
   PubMed Web of Science ®Google Scholar
• European Carotid Surgery Trialists' Collaborative Group. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial. Lancet 1996; 347(9015): 1591–3
   Google Scholar
• Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273(18): 1421–8
   PubMed Web of Science ®Google Scholar
• National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333(24): 1581–7
   PubMed Web of Science ®Google Scholar
• Jonas S. Anticoagulant therapy in cerebrovascular disease: review and metaanalysis. Stroke 1988; 19(8): 1043–8 [Erratum, Stroke 1989; 20(4): 562]
   PubMed Web of Science ®Google Scholar
• Yatsu FM, Hart RG, Mohr JP, et al. Anticoagulation of embolic strokes of cardiac origin: an update. Neurology 1988; 38(2): 314–6
   PubMed Web of Science ®Google Scholar
• Pessin MS, Estol CJ, Lafranchise F, et al. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993; 43(7): 1298–303
   Google Scholar
• Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338(8767): 597–600 [Erratum, Lancet 1991; 338(8772): 958]
   Google Scholar
• Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology 1988; 38(4): 517–22
   PubMed Web of Science ®Google Scholar
• Glantz MJ, Burger PC, Friedman AH, et al. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994; 44(11): 2020–7
   PubMed Web of Science ®Google Scholar
• Kay R, Wong KS, Yu YL, et al. Low- molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995; 333(24): 1588–93
   PubMed Web of Science ®Google Scholar